Employer-Paid

Employers are leaning on brokers to help them chart a path forward that offers employees value while minimizing cost.

The pharmaceutical giant sued Strive and several other compounders for distributing products containing tirzepatide, the primary ingredient in Lilly's GLP-1 weight-loss and diabetes medications.

The plans average 120 catastrophic diagnoses per year per 100,000 enrollees, a care manager reports.

The HRA Council and Centene are making a new push for bills that could make cash-for-coverage plans easier to use.

After years of deliberation, the state's Prescription Drug Affordability Review Board has enacted a cap on the price of Enbrel from Immunex Corp., which is used to treat rheumatoid arthritis and other autoimmune diseases.

While "many technology vendors are working to build AI agents," numerous solutions are actually rebrands of existing products meant to capture buyers' attention, says Eser Rizaoglu, senior director analyst in Gartner's HR Practice.